SE465928B - 1,2,4-triazolonfoereningar med antidepressiv aktivitet, foerfarande foer framstaellning av dessa och en farmaceutisk komposition - Google Patents

1,2,4-triazolonfoereningar med antidepressiv aktivitet, foerfarande foer framstaellning av dessa och en farmaceutisk komposition

Info

Publication number
SE465928B
SE465928B SE8404869A SE8404869A SE465928B SE 465928 B SE465928 B SE 465928B SE 8404869 A SE8404869 A SE 8404869A SE 8404869 A SE8404869 A SE 8404869A SE 465928 B SE465928 B SE 465928B
Authority
SE
Sweden
Prior art keywords
compound
formula
hydrogen
pharmaceutically acceptable
alkyl
Prior art date
Application number
SE8404869A
Other languages
English (en)
Swedish (sv)
Other versions
SE8404869D0 (sv
SE8404869L (sv
Inventor
R E Gammans
D W Smith
J P Yevich
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24145128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE465928(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8404869D0 publication Critical patent/SE8404869D0/xx
Publication of SE8404869L publication Critical patent/SE8404869L/xx
Publication of SE465928B publication Critical patent/SE465928B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE8404869A 1983-09-30 1984-09-28 1,2,4-triazolonfoereningar med antidepressiv aktivitet, foerfarande foer framstaellning av dessa och en farmaceutisk komposition SE465928B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/538,027 US4613600A (en) 1983-09-30 1983-09-30 Antidepressant 1,2,4-triazolone compounds

Publications (3)

Publication Number Publication Date
SE8404869D0 SE8404869D0 (sv) 1984-09-28
SE8404869L SE8404869L (sv) 1985-03-31
SE465928B true SE465928B (sv) 1991-11-18

Family

ID=24145128

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8404869A SE465928B (sv) 1983-09-30 1984-09-28 1,2,4-triazolonfoereningar med antidepressiv aktivitet, foerfarande foer framstaellning av dessa och en farmaceutisk komposition

Country Status (25)

Country Link
US (1) US4613600A (fr)
JP (1) JPS60100560A (fr)
KR (1) KR880002624B1 (fr)
AT (1) AT387963B (fr)
AU (1) AU561460B2 (fr)
BE (1) BE900714A (fr)
CA (1) CA1237723A (fr)
CH (1) CH661924A5 (fr)
CY (1) CY1541A (fr)
DE (1) DE3435745C2 (fr)
DK (1) DK169546B1 (fr)
ES (1) ES536286A0 (fr)
FI (1) FI83310C (fr)
FR (1) FR2552759B1 (fr)
GB (1) GB2147297B (fr)
GR (1) GR80475B (fr)
HK (1) HK37391A (fr)
IE (1) IE58084B1 (fr)
IT (1) IT1178522B (fr)
LU (1) LU85561A1 (fr)
MY (1) MY102123A (fr)
NL (1) NL8402946A (fr)
SE (1) SE465928B (fr)
YU (1) YU45667B (fr)
ZA (1) ZA847589B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
YU44721B (en) * 1983-11-30 1990-12-31 Bristol Myers Co Process for obtaining 4-(2-phenoxyethyl)-1,2,4-triazolone
CA1331757C (fr) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibant les 4-(4-phenyl-1-piperazinyl)phenols
US5504086A (en) * 1989-10-17 1996-04-02 Ellinwood, Jr.; Everett H. Intraoral dosing method of administering trifluorobenzodiazepines, propoxyphene, and nefazodone
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
DE4425144A1 (de) * 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung
US6403593B1 (en) 1995-07-14 2002-06-11 Abbott Laboratories Triazole compounds and the use thereof
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
JP2002541192A (ja) 1999-04-09 2002-12-03 セプラコール， インク． Ｓ−ヒドロキシネファゾドン
AU4215300A (en) 1999-04-09 2000-11-14 Sepracor, Inc. R-hydroxynefazodone
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP1737473A4 (fr) * 2004-04-19 2009-08-26 Noven Therapeutics Llc Combinaisons de lithium et utilisations associees
PT1889198E (pt) 2005-04-28 2015-03-06 Proteus Digital Health Inc Sistema fármaco-informático
WO2008036682A2 (fr) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Traitement des troubles hépatiques par l'administration de conjugués de protéine associée au récepteur (rap)
US9339500B2 (en) * 2008-03-04 2016-05-17 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2012072665A1 (fr) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprenant de la pipampérone et des antagonistes/inhibiteurs de la recapture de la sérotonine
US9072660B2 (en) 2011-09-09 2015-07-07 The Board Of Trustees Of The Leland Stanford Junior University Topical itraconazole formulations and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
IT1052119B (it) * 1972-10-16 1981-06-20 Sigma Tau Ind Farmaceuti Derivati del triazolinone e procedimento per la loro preparazione
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants

Also Published As

Publication number Publication date
AT387963B (de) 1989-04-10
IE58084B1 (en) 1993-06-30
FR2552759A1 (fr) 1985-04-05
GB2147297B (en) 1987-04-15
FI843779L (fi) 1985-03-31
MY102123A (en) 1992-03-31
JPS60100560A (ja) 1985-06-04
SE8404869D0 (sv) 1984-09-28
FI83310B (fi) 1991-03-15
CY1541A (en) 1991-03-22
YU172184A (en) 1986-10-31
DE3435745C2 (de) 1994-11-03
ES8601966A1 (es) 1985-11-16
AU561460B2 (en) 1987-05-07
JPH0542435B2 (fr) 1993-06-28
GB2147297A (en) 1985-05-09
KR850002270A (ko) 1985-05-10
GB8424535D0 (en) 1984-11-07
FI843779A0 (fi) 1984-09-26
NL8402946A (nl) 1985-04-16
US4613600A (en) 1986-09-23
HK37391A (en) 1991-05-24
GR80475B (en) 1985-01-31
ES536286A0 (es) 1985-11-16
IE842476L (en) 1985-03-30
IT1178522B (it) 1987-09-09
CA1237723A (fr) 1988-06-07
KR880002624B1 (ko) 1988-12-07
DE3435745A1 (de) 1985-04-11
LU85561A1 (fr) 1985-06-04
BE900714A (fr) 1985-03-28
ATA310884A (de) 1988-09-15
ZA847589B (en) 1985-05-29
DK468284A (da) 1985-03-31
FR2552759B1 (fr) 1988-10-07
CH661924A5 (de) 1987-08-31
FI83310C (fi) 1991-06-25
AU3364884A (en) 1985-04-04
IT8422922A0 (it) 1984-09-28
DK169546B1 (da) 1994-11-28
YU45667B (sh) 1992-07-20
DK468284D0 (da) 1984-09-28
SE8404869L (sv) 1985-03-31

Similar Documents

Publication Publication Date Title
SE465928B (sv) 1,2,4-triazolonfoereningar med antidepressiv aktivitet, foerfarande foer framstaellning av dessa och en farmaceutisk komposition
US4487773A (en) 1,2,4-Triazol-3-one antidepressants
KR880001374B1 (ko) 항우울증 치료제인 2-펜옥시알킬-1,2,4-트리아졸-3-온 및 그의 제조방법
US4524206A (en) 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
EA002778B1 (ru) СЕЛЕКТИВНЫЕ β-АДРЕНЕРГИЧЕСКИЕ АГОНИСТЫ
PL178546B1 (pl) Nowe, zasadniczo czyste optycznie, enancjomery prawoskrętne lub lewoskrętne 1-[(4-chlorofenylo)fenylometylo] piperazyny i sposób ich wytwarzania
CZ260295A3 (en) Indole derivatives as 5-ht1a and/or 5-ht2 ligands
HU223945B1 (hu) 1,2,3,4-Tetrahidro-kinoxalin-dion-származékok és ezeket tartalmazó gyógyszerkészítmények
EP0568437B1 (fr) Dérivés antidépresseurs 3-halophénylpiperazinyl propyl de triazolones et triazoldiones substituées
MXPA02006499A (es) Derivados de fenilpiperazinilo.
JP2840288B2 (ja) 置換１―（１ｈ―イミダゾール―４―イル）アルキル―ベンズアミド
CA2096475A1 (fr) Derives du benzimidazole; leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US4652565A (en) Piperazine derivatives, their production and pharmaceutical compositions containing them
CA2109816A1 (fr) Nouvelles amidoalkyl- et imidoalkylpiperazines
US4575555A (en) 4-(3-Chlorophenyl)-1,2,3,6-tetrahydropyridine derivative
WO1997028157A1 (fr) Nouveaux derives de la piperidine substitues en position 4 par un groupe imidazolidin-2-on-1-yl-ethyl, tetrahydropyrimidin-2-on-1-yl-ethyl, et 1,3-dia-zepin-2-on-1-yl-ethyl, et leurs applications comme antagonistes des recepteurs alpha-2 adrenergiques
US4386091A (en) 2-Phenoxyalkyl-1,2,4-triazol-3-one antidepressants
CA2007401A1 (fr) Derives des bisarylalcenes, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US6121264A (en) Imidazole-substituted quinoxalinedione derivatives
JP2002534421A (ja) １−フェニル−４−（１−［２−アリール］シクロプロピル）メチルピペラジン：ドーパミン受容体リガンド
FR2639944A1 (fr) Nouveaux derives de l'indole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JPH04288073A (ja) ピペラジン誘導体
KR880001375B1 (ko) 항우울증 치료제인 2-펜옥시알킬-1,2,4-트리아졸-3-온 및 그의 제조방법
CZ289526B6 (cs) (S) nebo (R) Enantiomer piperazinylové sloučeniny a způsob jeho přípravy
US4105768A (en) Hypotensive substituted 1,2,4-triazoles

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8404869-3

Format of ref document f/p: F

NUG Patent has lapsed